You are here

  • Home
  • Online First
  • Clinical genomics and the adult with congenital heart disease: new opportunities

Article Text

Article menu

other Versions

Download PDFPDF
PostScript
Correspondence
Clinical genomics and the adult with congenital heart disease: new opportunities
  1. Isma Rafiq,
  2. Leisa Freeman
  1. Cardiology Department, Norfolk and Norwich University Hospital, Norwich, UK
  1. Correspondence to Dr Isma Rafiq, Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, Norfolk, Norwich NR4 7 UY, UK; ismach{at}doctors.org.uk

https://doi.org/10.1136/heartjnl-2014-306802

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor

    We are intrigued by the article by Priest and Ashley.1 The importance of genomics has been clearly identified and the article beautifully describes the role of genetics in cardiovascular medicine but concentrates on inherited arrhythmias, cardiomyopathies and occasional pharmacogenomic profiling.1 We suggest they have failed to consider the large, unrecognised need for genomics in adults patients with congenital heart conditions.

    More than 90% of patients with congenital heart conditions now survive to adulthood and yet as neonates/children there was restricted availability of genetic testing and limited techniques. When such patients attend the adult clinic they want to know the …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Editorial
      Genomics in clinical practice
      James R Priest Euan A Ashley
      Heart 2014; 100 1569-1570 Published Online First: 25 Jul 2014. doi: 10.1136/heartjnl-2014-306111